Hepatitis B virus RNA-dependent DNA polymerase (HBV Pol)

The Hepatitis B virus RNA-dependent DNA polymerase, commonly referred to as the P protein, is a multifunctional enzyme essential for the replication of the Hepatitis B virus (HBV) (UniProt: P03156). It consists of four distinct domains: the terminal protein involved in priming, a spacer region, the reverse transcriptase domain, and the RNase H domain (PubMed: 25231598). The enzyme is unique among DNA viruses because it replicates its DNA genome via an RNA intermediate, known as pregenomic RNA, using reverse transcription (NIH: StatPearls). In the context of disease, this polymerase is the primary driver of viral load in chronic hepatitis B, which can lead to severe liver damage, cirrhosis, and hepatocellular carcinoma (PubMed: 30033833). Therapeutically, it is the principal target for nucleoside and nucleotide analogs (NRTIs) such as entecavir and tenofovir, which inhibit the enzyme's activity and cause DNA chain termination (PubChem). However, long-term treatment often faces challenges such as the emergence of drug-resistant mutations within the polymerase gene, necessitating careful monitoring of viral load and liver function (PubMed: 22446851).

Other names

P proteinHBV polymeraseReverse transcriptaseDNA-directed DNA polymeraseRNA-directed DNA polymerasePol protein

Nucleoside and nucleotide analogs act as competitive inhibitors of the polymerase; once incorporated into the nascent viral DNA chain, they cause premature chain termination, thereby halting viral replication.